Data as of Dec 05
| +0.58 / +0.60%|
The 21 analysts offering 12-month price forecasts for Allergan Inc have a median target of 104.00, with a high estimate of 145.00 and a low estimate of 83.00. The median estimate represents a +7.77% increase from the last price of 96.50.
The current consensus among 23 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.